Recent Insights » Case Studies » Recruitment Case Study for Osteoarthritis Pain Program

× Share this Presentation

Facebook
Twitter
Email
LinkedIn

Recruitment Case Study for Osteoarthritis Pain Program

August 3, 2018

Share this Flipbook
Facebook
Twitter
Email
LinkedIn

Previous Flipbook

OhioHealth Case Study

Dissatisfied with its electronic IRB research management solution, OhioHealth Research & Innovation Institu...

Next Flipbook

WCG ThreeWire Recruitment Success: 70% of Total Randomization

Most Recent Flipbooks

WCG Independent Site Network For Sites

Case Study

WCG Case Study - Alleviating Critical Staffing Challenges for Cedars-Sinai

Case Study

Partnering with WCG Saved Small Biotech Over $12K Each Month

Case Study

WCG’s PV Services Smooths Path to Approval for Emerging Biopharma

Case Study

WCG MRS Case Study - Franciscan Health

Case Study

Case Study - Leading Sponsor Delivers Enrollment 24 Months Ahead of Schedule With WCG Site Augmentation

Case Study

Post-Partum Depression Case Study: WCG Services for CNS Trials

Case Study

Movement Disorder Case Study: WCG Services for CNS Trials

Case Study

WCG Velos Case Study - Cancer Center

Case Study

Case Study - Avoca CQMS Consulting

Case Study

Case Study - Avoca Mock Inspection Consulting

Case Study

Case Study - WCG Helps Sponsor Secure 200 Investigators in 5 Days

Case Study

Case Study - Eliminating 98,166 Hours of Redundant Study Training

Case Study

Case Study - Making Study Training More Effective and Engaging for Endo

Case Study

WCG Supports Small Oncology Biotech Through Rapid Growth, Saving Hundreds of Thousands of Dollars

Case Study

Case Study - Leading Pharma Enrolls 56% Faster with WCG Site Augmentation

Case Study

Helping Your Sites Meet Their Full Potential in Oncology

Case Study

Case Study - Top 5 Sponsor Enrolls 30,000+ Patients in Just Over 3 Months With WCG Site Augmentation

Case Study

How WCG Statistics Collaborative Helped Breakthrough Therapy Obtain Regulatory Approval

Case Study

See How WCG Helped a Mid-tier Biopharma Respond to an Urgent FDA Request, and Adjudicate 400 Endpoints in Just a Few Short Weeks

Case Study

Return to Home